Articles

The New Mexico State Senate recently defeated a bill which would have required the public reporting of incentives paid to health care professionals for participation in marketing research studies sponsored by pharmaceutical, medical device or medical supply manufacturers.

Today, the Marketing Research Association (MRA) applauded the U.S. Congress for including $1 billion in immediate funding for the decennial Census in the just-approved economic stimulus law. MRA had advocated for the inclusion of this funding in the bill throughout the process and successfully helped fend off attempts in the Senate to eliminate the funds.

Louisiana H.B. 1044 – a bill drafted by CMOR – has passed both the State House and Senate with unanimous approval and awaits the signature of Governor Bobby Jindal (R). The proposed law would combat political persuasion calls (also known as ‘political telemarketing’ or ‘push polls’) while protecting legitimate survey and opinion research (including message testing).

Louisiana Act 810 – legislation drafted by CMOR – which had passed both the State House and Senate with unanimous approval was signed yesterday by Governor Bobby Jindal (R). The law will combat political persuasion calls (also known as ‘political telemarketing’ or ‘push polls’) while protecting legitimate survey and opinion research (including message testing).

What are the federal income tax reporting requirements for incentives offered for participation in research?

CMOR in late February helped defeat Louisiana House Bill 58—legislation that would have severely harmed political survey and opinion research with residents of Louisiana.

In 1981, the R&D Tax Credit (also known as the Research & Experimentation Tax Credit) was signed into law. It was envisioned as a temporary measure to incentivize companies to keep high-tech jobs in the United States and boost corporate growth. Since then, the tax credit has been extended at least a dozen times.According to the explanations on IRS Form 6765 , research expenditures that qualify for the credit “ must be undertaken for discovering information that is technological in ...

In less than a month’s time, CMOR convinced Florida election officials to retract an advisory opinion which would have prohibited political issue polling in Florida.

Pharmaceutical marketing research and data analytics companies should not be required to assume responsibility for formal reporting of adverse events (AEs) uncovered during routine pharmaceutical marketing research and data analytics in the U.S. because:

Effective October 1, 2006, information services are subject to New Jersey sales and use tax.